Real-World Use of Molecular Testing for Endometrial Cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study examines how hospitals in Italy use molecular testing (genetic analysis) to better classify and treat endometrial cancer. It may help doctors personalize treatment based on the cancer's molecular characteristics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You work at or are treated at an Italian hospital involved in endometrial cancer care
- The hospital participates in surgical treatment of endometrial cancer
- Your hospital is willing to participate in the study and share data
- You have been diagnosed with endometrial cancer (cancer of the uterine lining)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
This study looks at combining genetic testing with surgical exams to better understand endometrial cancer. It may help doctors see which treatments could work best for you.
This study looks at women with certain high-risk types of endometrial cancer that have not spread into the muscle wall of the uterus. It aims to understand how these cancers behave and whether lymph node testing is needed, which could help guide treatment decisions.
This study looks at the specific type of endometrial cancer (endometrioid) in Mexican patients to understand how different molecular features affect prognosis. It may help doctors better tailor treatment to the individual.
This study tests whether using genetic information (molecular classification) along with standard factors helps decide if you should have radiation after surgery for early-stage uterine cancer. It aims to improve treatment and reduce side effects.
This study tests two less invasive methods—sampling cells from the lining of the uterus (endometrial cytology) and checking DNA changes in the cervix—to see if they can help detect endometrial cancer or atypical hyperplasia, and to monitor response in people who are preserving their fertility. It aims to find a gentler alternative to traditional biopsy.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.